Bayer Aktiengesellschaft (ETR:BAYN – Get Free Report)’s stock price passed above its 50 day moving average during trading on Friday. The stock has a 50 day moving average of €47.14 and traded as high as €48.00. Bayer Aktiengesellschaft shares last traded at €47.96, with a volume of 2,663,942 shares.
Bayer Aktiengesellschaft Stock Performance
The company’s 50-day moving average price is €47.14 and its two-hundred day moving average price is €43.46. The company has a debt-to-equity ratio of 129.90, a quick ratio of 0.72 and a current ratio of 1.04. The stock has a market cap of $51.06 billion, a PE ratio of -58.03, a PEG ratio of 36.39 and a beta of 0.84.
Bayer Aktiengesellschaft Company Profile
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines for self-medication and self-care; and solutions for nutritional supplements, allergy, cough and cold, dermatology, pain and cardiovascular risk prevention, and digestive health.
Featured Stories
- Five stocks we like better than Bayer Aktiengesellschaft
- Amazon’s Record Margins Couldn’t Stop the Sell-Off—Here’s Why
- DoorDash’s $17 Billion Bet on Instacart Faces a Long Regulatory Road Ahead
- FTC Puts A Wrinkle In the Cintas and UniFirst Merger
- Breaching the Valuation: The Real Reason Fortinet Dropped
Receive News & Ratings for Bayer Aktiengesellschaft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer Aktiengesellschaft and related companies with MarketBeat.com's FREE daily email newsletter.
